Goldman Sachs Group »

Monopar Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Monopar Therapeutics (MNPR) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Monopar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monopar Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monopar Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $533k 6.5k 81.67
2025-03-31 $673k 19k 36.41

More positions owned by Goldman Sachs Group

Nvidia Corporation CMN (NVDA)
Spdr S&p 500 Etf Tr CMN (SPY)
Microsoft Corp CMN (MSFT)
Apple CMN (AAPL)
Invesco Qqq Tr CMN Put Option (QQQ)
Tesla CMN (TSLA)
Amazon CMN (AMZN)
Meta Platforms CMN (META)
Alphabet CMN (GOOGL)
Broadcom CMN (AVGO)
Ishares Tr CMN (IVV)
Ishares Tr CMN Put Option (IWM)
Vanguard Index Fds CMN (VOO)
Ishares Tr CMN Put Option (HYG)
Jpmorgan Chase & Co. CMN (JPM)

View all positions for Goldman Sachs Group

Top funds holding Monopar Therapeutics

Henderson Group
Adage Capital Partners GP
RA Capital Management
Wellington Management Company
Vanguard Group
BlackRock
Deerfield Management Company
Saturn V Capital Management
TCG Crossover Management
ADAR1 Capital Management
Vivo Capital
Geode Capital Management
Affinity Asset Advisors
State Street Corporation
Driehaus Capital Management

View all funds holding Monopar Therapeutics